Official website of the Department of Homeland Security

Consistent with CDC guidance, most Office of Inspector General employees are currently serving the American people remotely. We are determined to keep interruptions to our operations to a minimum, and we appreciate your patience during this time.

Information and guidance about COVID-19 is available at coronavirus.gov.

Review of U.S. Customs and Border Protection's Fiscal Year 2018 Drug Control Performance Summary Report

Executive Summary

The Office of National Drug Control Policy’s (ONDCP) Circular, Accounting of Drug Control Funding and Performance Summary, requires each National Drug Control Program agency to submit to ONDCP Director a detailed accounting of all funds expended for National Drug Control Program activities during the previous fiscal year. Williams, Adley & Company – DC, LLP (Williams Adley), under contract with the Department of Homeland Security OIG, issued an Independent Accountant’s Report on U.S. Customs and Border Protection’s (CBP) FY 2018 Drug Control Performance Summary Report.

Report Number

OIG-19-26

Issue Date

03/08/2019

Document File

DHS Agency

Oversight Area

Keywords

Fiscal Year

2019